Top

Published in:

Open Access 01-12-2022 | Sarcopenia | Correction

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus

Authors: Huifang Dai, Jing Xu

Excerpt

Correction: BMC Musculoskelet Disord 23, 672 (2022) …

Dai H, Xu J. Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus. BMC Musculoskelet Disord. 2022;23:672. https://doi.org/10.1186/s12891-022-05636-8.CrossRefPubMedPubMedCentral

Title: Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
Authors: Huifang Dai
Jing Xu
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Sarcopenia
Osteoporosis
Osteoporosis
Published in: BMC Musculoskeletal Disorders / Issue 1/2022
Electronic ISSN: 1471-2474
DOI: https://doi.org/10.1186/s12891-022-05707-w